rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2010-1-15
|
pubmed:abstractText |
Sustained blood cell production depends on divisions by hematopoietic stem cells (HSCs) that yield both differentiating progeny as well as new HSCs via self-renewal. Differentiating progeny remain capable of self-renewal, but only HSCs sustain self-renewal through successive divisions securely enough to maintain clones that persist life-long. Until recently, the first identified next stage consisted of "short-term" reconstituting cells able to sustain clones of differentiating cells for only 4-6 weeks. Here we expand evidence for a numerically dominant "intermediate-term" multipotent HSC stage in mice whose clones persist for 6-8 months before becoming extinct and that are separable from both short-term as well as permanently reconstituting "long-term" HSCs. The findings suggest that the first step in stem cell differentiation consists not in loss of initial capacity for serial self-renewal divisions, but rather in loss of mechanisms that stabilize self-renewing behavior throughout successive future stem cell divisions.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD34,
http://linkedlifedata.com/resource/pubmed/chemical/CD150 antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Flt3 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Integrin alpha2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cell Surface,
http://linkedlifedata.com/resource/pubmed/chemical/fms-Like Tyrosine Kinase 3
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1875-9777
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2010 Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
8
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
48-58
|
pubmed:meshHeading |
pubmed-meshheading:20074534-Animals,
pubmed-meshheading:20074534-Antigens, CD,
pubmed-meshheading:20074534-Antigens, CD34,
pubmed-meshheading:20074534-Cell Differentiation,
pubmed-meshheading:20074534-Cell Division,
pubmed-meshheading:20074534-Cell Lineage,
pubmed-meshheading:20074534-Cell Separation,
pubmed-meshheading:20074534-Cells, Cultured,
pubmed-meshheading:20074534-Gene Expression Profiling,
pubmed-meshheading:20074534-Gene Expression Regulation,
pubmed-meshheading:20074534-Hematopoietic Stem Cells,
pubmed-meshheading:20074534-Integrin alpha2,
pubmed-meshheading:20074534-Mice,
pubmed-meshheading:20074534-Mice, Inbred C57BL,
pubmed-meshheading:20074534-Receptors, Cell Surface,
pubmed-meshheading:20074534-Time Factors,
pubmed-meshheading:20074534-fms-Like Tyrosine Kinase 3
|
pubmed:year |
2010
|
pubmed:articleTitle |
Intermediate-term hematopoietic stem cells with extended but time-limited reconstitution potential.
|
pubmed:affiliation |
Ontario Cancer Institute, Toronto, ON M5G 2M9, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|